Bothell, WA, United States of America

Divya Awasthi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Seagen Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Divya Awasthi. Retrieved from https://idiyas.com/inventor/divya-awasthi-cybnb2gv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Divya Awasthi

Introduction

Divya Awasthi is a notable inventor based in Bothell, WA (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative patent that addresses selective drug release mechanisms.

Latest Patents

Divya Awasthi holds a patent for "Selective drug release from internalized conjugates of biologically active compounds." This invention involves conjugates of biologically active compounds that include a sequence of amino acids with a tripeptide. This tripeptide allows for selective cleavage by tumor tissue homogenate, facilitating the release of free drugs and improving biodistribution into tumor tissues compared to normal tissues. This advancement is particularly relevant for patients requiring therapeutically effective amounts of drug conjugates.

Career Highlights

Divya Awasthi is currently employed at Seagen Inc., a company known for its focus on developing innovative cancer therapies. Her work at Seagen has positioned her as a key player in the advancement of targeted drug delivery systems.

Collaborations

Throughout her career, Divya has collaborated with talented individuals such as Noah Bindman and Nicole Okeley. These collaborations have further enhanced her research and development efforts in the field of biologically active compounds.

Conclusion

Divya Awasthi's contributions to the field of drug delivery through her innovative patent demonstrate her commitment to improving therapeutic outcomes for patients. Her work at Seagen Inc. and collaborations with fellow researchers highlight her significant role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…